Metraipolis › archive › dc_da3f46e21501

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer — Europe PMC PMID:42099018

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42099018
DOI
10.1002/kjm2.70228
License (as archived)
solo-consultazione
Archived
2026-11-02T15:14:44.589Z
SHA-256 of the archived text
0339832ba48e1bb65d58a654a1477760f4e521a6f4875ede1c444424af4aeafd
Stable URL of this page
https://metraipolis.com/documento/dc_da3f46e21501

How to cite

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer — Europe PMC PMID:42099018 — Europe PMC (en), https://europepmc.org/article/MED/42099018 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da3f46e21501 (Metraipolis archive dc_da3f46e21501, sha256 0339832ba48e1bb65d58a654a1477760f4e521a6f4875ede1c444424af4aeafd)
BibTeX
@misc{dcda3f46e21501,
  title = {Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple-Positive Breast Cancer — Europe PMC PMID:42099018},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42099018},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da3f46e21501; sha256 0339832ba48e1bb65d58a654a1477760f4e521a6f4875ede1c444424af4aeafd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42099018. Agents can read the archived copy with the MCP tool read_document.